WGS250509C40000
- 0.00
- 0.000.00%
GeneDx Holdings Newsroom
Press Release: GeneDx Announces Completion of Fabric Genomics Acquisition
GeneDx Announces Completion of Fabric Genomics Acquisition
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Jefferies Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $80
Analysts Have Conflicting Sentiments on These Healthcare Companies: GeneDx Holdings (WGS) and Dexcom (DXCM)
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $110
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
GeneDx Holdings Price Target Cut to $110.00/Share From $135.00 by TD Securities
GeneDx Holdings Is Maintained at Buy by TD Securities
Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Lowers Price Target to $78
GeneDx Holdings Analyst Ratings
Small U.S. Stocks Decrease; GeneDx Holdings Falls Furthest
GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript Summary
GeneDx Raises 2025 Revenue Guidance to $360M-$375M and Expands NICU Offerings
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
GeneDx Holdings Down Nearly 39%, On Pace For Record Percent Decrease -- Data Talk
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Xencor (XNCR) and GeneDx Holdings (WGS)
Sector Update: Health Care Stocks Decline Pre-Bell Wednesday
12 Health Care Stocks Moving In Wednesday's Pre-Market Session